Near-infrared fluorescence: application to in vivo molecular imaging

Current Opinion in Chemical Biology

Volumn 14, Issue 1, 2010, Pages 71-79

  Hilderbrand, Scott A ^a   Weissleder, Ralph ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOFLUORESCENCE; BIOCOMPATIBILITY; FLUORESCENCE; IN VIVO STUDY; MOLECULAR IMAGING; MOLECULAR PROBE; NONHUMAN; REVIEW;

ANIMALS; FLUORESCENCE; FLUORESCENT DYES; HUMANS; MOLECULAR IMAGING; PROTEINS; QUANTUM DOTS; SPECTROSCOPY, NEAR-INFRARED;

EID: 75149168815     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpa.2009.09.029     Document Type: Review

References (83)

1. Boumaza S., Arribas S.M., Osborne-Pellegrin M., McGrath J.C., Laurent S., Lacolley P., and Challande P. Fenestrations of the carotid internal elastic lamina and structural adaptation in stroke-prone spontaneously hypertensive rats. Hypertension 37 (2001) 1101-1107
2. Lee W.K., Bell J., Kilpatrick E., Hayes M., Lindop G.B., and Dominiczak M.H. Collagen-linked fluorescence in human atherosclerotic plaques. Atherosclerosis 98 (1993) 219-227
3. Owens S.L. Indocyanine green angiography. Br J Ophthalmol 80 (1996) 263-266
4. East J.M., Valentine C.S., Kanchev E., and Blake G.O. Sentinel lymph node biopsy for breast cancer using methylene blue dye manifests a short learning curve among experienced surgeons: a prospective tabular cumulative sum (CUSUM) analysis. BMC Surg 9 (2009) 2
5. Kiesslich R., Fritsch J., Holtmann M., Koehler H.H., Stolte M., Kanzler S., Nafe B., Jung M., Galle P.R., and Neurath M.F. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 124 (2003) 880-888
6. Tung C.H., Lin Y., Moon W.K., and Weissleder R. A receptor-targeted near-infrared fluorescence probe for in vivo tumor imaging. Chembiochem 3 (2002) 784-786
7. Johnson J.R., Fu N., Arunkumar E., Leevy W.M., Gammon S.T., Piwnica-Worms D., and Smith B.D. Squaraine rotaxanes: superior substitutes for Cy-5 in molecular probes for near-infrared fluorescence cell imaging. Angew Chem Int Ed 46 (2007) 5528-5531
8. Bhushan K.R., Tanaka E., and Frangioni J.V. Synthesis of conjugatable bisphosphonates for molecular imaging of large animals. Angew Chem Int Ed 46 (2007) 7969-7971
9. Aikawa E., Nahrendorf M., Sosnovik D., Lok V.M., Jaffer F.A., Aikawa M., and Weissleder R. Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation 115 (2007) 377-386
10. Jin Z.H., Josserand V., Foillard S., Boturyn D., Dumy P., Favrot M.C., and Coll J.L. In vivo optical imaging of integrin alphaV-beta3 in mice using multivalent or monovalent cRGD targeting vectors. Mol Cancer 6 (2007) 41
11. Montet X., Montet-Abou K., Reynolds F., Weissleder R., and Josephson L. Nanoparticle imaging of integrins on tumor cells. Neoplasia 8 (2006) 214-222
12. Tung C.H., Ho N.H., Zeng Q., Tang Y., Jaffer F.A., Reed G.L., and Weissleder R. Novel factor XIII probes for blood coagulation imaging. Chembiochem 4 (2003) 897-899
13. McCarthy J.R., Patel P., Botnaru I., Haghayeghi P., Weissleder R., and Jaffer F.A. Multimodal nanoagents for the detection of intravascular thrombi. Bioconjug Chem 20 (2009) 1251-1255
14. Citrin D., Lee A.K., Scott T., Sproull M., Menard C., Tofilon P.J., and Camphausen K. In vivo tumor imaging in mice with near-infrared labeled endostatin. Mol Cancer Ther 3 (2004) 481-488
15. Ke S., Wen X., Gurfinkel M., Charnsangavej C., Wallace S., Sevick-Muraca E.M., and Li C. Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts. Cancer Res 63 (2003) 7870-7875
16. Schellenberger E.A., Bogdanov Jr. A., Petrovsky A., Ntziachristos V., Weissleder R., and Josephson L. Optical imaging of apoptosis as a biomarker of tumor response to chemotherapy. Neoplasia 5 (2003) 187-192
17. Devaraj N.K., Weissleder R., and Hilderbrand S.A. Tetrazine-based cycloadditions: application to pretargeted live cell imaging. Bioconjug Chem 19 (2008) 2297-2299
18. Hilger I., Leistner Y., Berndt A., Fritsche C., Haas K.M., Kosmehl H., and Kaiser W.A. Near-infrared fluorescence imaging of HER-2 protein over-expression in tumour cells. Eur Radiol 14 (2004) 1124-1129
19. Rosenthal E.L., Kulbersh B.D., King T., Chaudhuri T.R., and Zinn K.R. Use of fluorescent labeled anti-epidermal growth factor receptor antibody to image head and neck squamous cell carcinoma xenografts. Mol Cancer Ther 6 (2007) 1230-1238
20. Matter C.M., Schuler P.K., Alessi P., Meier P., Ricci R., Zhang D., Halin C., Castellani P., Zardi L., Hofer C.K., et al. Molecular imaging of atherosclerotic plaques using a human antibody against the extra-domain B of fibronectin. Circ Res 95 (2004) 1225-1233
21. Hansch A., Frey O., Sauner D., Hilger I., Haas M., Malich A., Brauer R., and Kaiser W.A. In vivo imaging of experimental arthritis with near-infrared fluorescence. Arthritis Rheum 50 (2004) 961-967
22. Ikanovic M., Rudzinski W.E., Bruno J.G., Allman A., Carrillo M.P., Dwarakanath S., Bhahdigadi S., Rao P., Kiel J.L., and Andrews C.J. Fluorescence assay based on aptamer-quantum dot binding to Bacillus thuringiensis spores. J Fluoresc 17 (2007) 193-199
23. Bagalkot V., Zhang L., Levy-Nissenbaum E., Jon S., Kantoff P.W., Langer R., and Farokhzad O.C. Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer. Nano Lett 7 (2007) 3065-3070
24. Tung C.H., Mahmood U., Bredow S., and Weissleder R. In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. Cancer Res 60 (2000) 4953-4958
25. Jaffer F.A., Kim D.E., Quinti L., Tung C.H., Aikawa E., Pande A.N., Kohler R.H., Shi G.P., Libby P., and Weissleder R. Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensor. Circulation 115 (2007) 2292-2298
26. Messerli S.M., Prabhakar S., Tang Y., Shah K., Cortes M.L., Murthy V., Weissleder R., Breakefield X.O., and Tung C.H. A novel method for imaging apoptosis using a caspase-1 near-infrared fluorescent probe. Neoplasia 6 (2004) 95-105
27. Bremer C., Tung C.H., and Weissleder R. In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat Med 7 (2001) 743-748
28. Xing B., Khanamiryan A., and Rao J. Cell-permeable near-infrared fluorogenic substrates for imaging beta-lactamase activity. J Am Chem Soc 127 (2005) 4158-4159
29. Zhang X.A., Lovejoy K.S., Jasanoff A., and Lippard S.J. Water-soluble porphyrins as a dual-function molecular imaging platform for MRI and fluorescence zinc sensing. Proc Natl Acad Sci U S A 104 (2007) 10780-10785
30. Kiyose K., Kojima H., Urano Y., and Nagano T. Development of a ratiometric fluorescent zinc ion probe in near-infrared region, based on tricarbocyanine chromophore. J Am Chem Soc 128 (2006) 6548-6549
31. Hilderbrand S.A., Kelly K.A., Niedre M., and Weissleder R. Near infrared fluorescence-based bacteriophage particles for ratiometric pH imaging. Bioconjug Chem 19 (2008) 1635-1639
32. Zhang Z., and Achilefu S. Design, synthesis and evaluation of near-infrared fluorescent pH indicators in a physiologically relevant range. Chem Commun (2005) 5887-5889
33. Sasaki E., Kojima H., Nishimatsu H., Urano Y., Kikuchi K., Hirata Y., and Nagano T. Highly sensitive near-infrared fluorescent probes for nitric oxide and their application to isolated organs. J Am Chem Soc 127 (2005) 3684-3685
34. Lee D., Khaja S., Velasquez-Castano J.C., Dasari M., Sun C., Petros J., Taylor W.R., and Murthy N. In vivo imaging of hydrogen peroxide with chemiluminescent nanoparticles. Nat Mater 6 (2007) 765-769. A unique strategy to avoid complications from tissue autofluorescence by engineering of chemiluminescent far-red emitting nanoparticles that are sensitive to hydrogen peroxide.
35. Albers A.E., Dickinson B.C., Miller E.W., and Chang C.J. A red-emitting naphthofluorescein-based fluorescent probe for selective detection of hydrogen peroxide in living cells. Bioorg Med Chem Lett 18 (2008) 5948-5950
36. Kundu K., Knight S.F., Willett N., Lee S., Taylor W.R., and Murthy N. Hydrocyanines: a class of fluorescent sensors that can image reactive oxygen species in cell culture, tissue, and in vivo. Angew Chem Int Ed 48 (2009) 299-303
37. Shepherd J., Hilderbrand S.A., Waterman P., Heinecke J.W., Weissleder R., and Libby P. A fluorescent probe for the detection of myeloperoxidase activity in atherosclerosis-associated macrophages. Chem Biol 14 (2007) 1221-1231
38. Kelly K.A., Waterman P., and Weissleder R. In vivo imaging of molecularly targeted phage. Neoplasia 8 (2006) 1011-1018
39. Choi H.S., Ipe B.I., Misra P., Lee J.H., Bawendi M.G., and Frangioni J.V. Tissue- and organ-selective biodistribution of NIR fluorescent quantum dots. Nano Lett 9 (2009) 2354-2359
40. Nahrendorf M., Waterman P., Thurber G., Groves K., Rajopadhye M., Panizzi P., Marinelli B., Aikawa E., Pittet M.J., Swirski F.K., et al. Hybrid in vivo FMT-CT imaging of protease activity in atherosclerosis with customized nanosensors. Arterioscler Thromb Vasc Biol 29 (2009) 1444-1451. This work demonstrates three-dimensional FMT-CT multimodal fusion techniques, a method with powerful diagnostic implications, and presents a detailed investigation on the effects of nanoparticle imaging agent size on in vivo performance.
41. Choi H.S., Liu W., Misra P., Tanaka E., Zimmer J.P., Itty Ipe B., Bawendi M.G., and Frangioni J.V. Renal clearance of quantum dots. Nat Biotechnol 25 (2007) 1165-1170. An excellent and detailed investigation on the impact of nanoparticle-based imaging agent size and surface charge on their pharmacokinetics and clearance.
42. Burns A.A., Vider J., Ow H., Herz E., Penate-Medina O., Baumgart M., Larson S.M., Wiesner U., and Bradbury M. Fluorescent silica nanoparticles with efficient urinary excretion for nanomedicine. Nano Lett 9 (2009) 442-448
43. Yang Z., Leon J., Martin M., Harder J.W., Zhang R., Liang D., Lu W., Tian M., Gelovani J.G., Qiao A., et al. Pharmacokinetics and biodistribution of near-infrared fluorescence polymeric nanoparticles. Nanotechnology 20 (2009) 165101
44. Cedervall T., Lynch I., Lindman S., Berggard T., Thulin E., Nilsson H., Dawson K.A., and Linse S. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci U S A 104 (2007) 2050-2055
45. Kim H.R., Andrieux K., Delomenie C., Chacun H., Appel M., Desmaele D., Taran F., Georgin D., Couvreur P., and Taverna M. Analysis of plasma protein adsorption onto PEGylated nanoparticles by complementary methods: 2-DE, CE and protein lab-on-chip system. Electrophoresis 28 (2007) 2252-2261
46. Ogawa M., Kosaka N., Choyke P.L., and Kobayashi H. Tumor-specific detection of an optically targeted antibody combined with a quencher-conjugated neutravidin "quencher-chaser": a dual "quench and chase" strategy to improve target to nontarget ratios for molecular imaging of cancer. Bioconjug Chem 20 (2009) 147-154
47. Agard N.J., Prescher J.A., and Bertozzi C.R. A strain-promoted [3 + 2] azide-alkyne cycloaddition for covalent modification of biomolecules in living systems. J Am Chem Soc 126 (2004) 15046-15047
48. Laughlin S.T., Baskin J.M., Amacher S.L., and Bertozzi C.R. In vivo imaging of membrane-associated glycans in developing zebrafish. Science 320 (2008) 664-667. The excellent demonstration of a rapid copper-free 'click' reaction for the in vivo imaging of cell-surface glycans.
49. Blackman M.L., Royzen M., and Fox J.M. Tetrazine ligation: fast bioconjugation based on inverse-electron-demand Diels-Alder reactivity. J Am Chem Soc 130 (2008) 13518-13519
50. Devaraj N.K., Upadhyay R., Haun J.B., Hilderbrand S.A., and Weissleder R. Fast and sensitive pretargeted labeling of cancer cells through a tetrazine/trans-cyclooctene cycloaddition. Angew Chem Int Ed 48 (2009) 7013-7016. An excellent demonstration of a rapid bio-orthogonal coupling reaction on cell surfaces, with strong implications for future in vivo molecular imaging applications.
51. Mancini M.C., Kairdolf B.A., Smith A.M., and Nie S. Oxidative quenching and degradation of polymer-encapsulated quantum dots: new insights into the long-term fate and toxicity of nanocrystals in vivo. J Am Chem Soc 130 (2008) 10836-10837
52. Li L., Daou J., Texier I., Chi T.T.K., Liem K.C., and Reiss P. Highly luminescent CuIn2S2/ZnS core/shell nanocrystals: cadmium-free quantum dots for in vivo imaging. Chem Mater 21 (2009) 2422-2429
53. Yong K.-T., Ding H., Roy I., Law W.-C., Bergey E.J., Maitra A., and Prasad P.N. Imaging pancreatic cancer using bioconjugated InP quantum dots. ACS Nano 3 (2009) 502-510
54. Park J.H., Gu L., von Maltzahn G., Ruoslahti E., Bhatia S.N., and Sailor M.J. Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nat Mater 8 (2009) 331-336
55. Altinoglu E.I., Russin T.J., Kaiser J.M., Barth B.M., Eklund P.C., Kester M., and Adair J.H. Near-infrared emitting fluorophore-doped calcium phosphate nanoparticles for in vivo imaging of human breast cancer. ACS Nano 2 (2008) 2075-2084
56. Shaw S.Y., Westly E.C., Pittet M.J., Subramanian A., Schreiber S.L., and Weissleder R. Perturbational profiling of nanomaterial biologic activity. Proc Natl Acad Sci U S A 105 (2008) 7387-7392. One of the shortcomings of nanoparticle-based imaging agents is the absence of detailed toxicity information. In this work, a systematic in vitro screening methodology is developed to address this issue.
57. Swirski F.K., Nahrendorf M., Etzrodt M., Wildgruber M., Cortez-Retamozo V., Panizzi P., Figueiredo J.L., Kohler R.H., Chudnovskiy A., Waterman P., et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 325 (2009) 612-616
58. Kobayashi H., Koyama Y., Barrett T., Hama Y., Regino C.A., Shin I.S., Jang B.S., Le N., Paik C.H., Choyke P.L., et al. Multimodal nanoprobes for radionuclide and five-color near-infrared optical lymphatic imaging. ACS Nano 1 (2007) 258-264. Excellent demonstration on the potential of optical imaging techniques for the visualization of signal in five separate imaging channels.
59. Koyama Y., Barrett T., Hama Y., Ravizzini G., Choyke P.L., and Kobayashi H. In vivo molecular imaging to diagnose and subtype tumors through receptor-targeted optically labeled monoclonal antibodies. Neoplasia 9 (2007) 1021-1029
60. Ntziachristos V., Ripoll J., Wang L.V., and Weissleder R. Looking and listening to light: the evolution of whole-body photonic imaging. Nat Biotechnol 23 (2005) 313-320
61. Josephson L., Kircher M.F., Mahmood U., Tang Y., and Weissleder R. Near-infrared fluorescent nanoparticles as combined MR/optical imaging probes. Bioconjug Chem 13 (2002) 554-560
62. 3+-functionalized near-infrared quantum dots for in vivo dual modal (fluorescence/magnetic resonance) imaging. Chem Commun (2008) 5764-5766
63. Park J.H., von Maltzahn G., Ruoslahti E., Bhatia S.N., and Sailor M.J. Micellar hybrid nanoparticles for simultaneous magnetofluorescent imaging and drug delivery. Angew Chem Int Ed 47 (2008) 7284-7288. In this publication, the use of NIR luminescent porous silicon nanoparticles is detailed for the first time for in vivo imaging. These materials are nontoxic, biodegradable, and can incorporate therapeutics.
64. Christen T., Nahrendorf M., Wildgruber M., Swirski F.K., Aikawa E., Waterman P., Shimizu K., Weissleder R., and Libby P. Molecular imaging of innate immune cell function in transplant rejection. Circulation 119 (2009) 1925-1932
65. McCann C.M., Waterman P., Figueiredo J.L., Aikawa E., Weissleder R., and Chen J.W. Combined magnetic resonance and fluorescence imaging of the living mouse brain reveals glioma response to chemotherapy. Neuroimage 45 (2009) 360-369
66. Medarova Z., Rashkovetsky L., Pantazopoulos P., and Moore A. Multiparametric monitoring of tumor response to chemotherapy by noninvasive imaging. Cancer Res 69 (2009) 1182-1189
67. Cai W., Chen K., Li Z.B., Gambhir S.S., and Chen X. Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature. J Nucl Med 48 (2007) 1862-1870
68. Dullin C., Zientkowska M., Napp J., Missbach-Guentner J., Krell H.W., Muller F., Grabbe E., Tietze L.F., and Alves F. Semiautomatic landmark-based two-dimensional-three-dimensional image fusion in living mice: correlation of near-infrared fluorescence imaging of Cy5.5-labeled antibodies with flat-panel volume computed tomography. Mol Imaging 8 (2009) 2-14
69. Inoue Y., Izawa K., Kiryu S., Tojo A., and Ohtomo K. Diet and abdominal autofluorescence detected by in vivo fluorescence imaging of living mice. Mol Imaging 7 (2008) 21-27
70. Pham W., Cassell L., Gillman A., Koktysh D., and Gore J.C. A near-infrared dye for multichannel imaging. Chem Commun (2008) 1895-1897
71. Kumar R., Ohulchanskyy T.Y., Roy I., Gupta S.K., Borek C., Thompson M.E., and Prasad P.N. Near-infrared phosphorescent polymeric nanomicelles: efficient optical probes for tumor imaging and detection. ACS Appl Mater Interface 1 (2009) 1474-1481
72. Akers W., Lesage F., Holten D., and Achilefu S. In vivo resolution of multiexponential decays of multiple near-infrared molecular probes by fluorescence lifetime-gated whole-body time-resolved diffuse optical imaging. Mol Imaging 6 (2007) 237-246
73. Goiffon R.J., Akers W.J., Berezin M.Y., Lee H., and Achilefu S. Dynamic noninvasive monitoring of renal function in vivo by fluorescence lifetime imaging. J Biomed Opt 14 (2009) 020501
74. So M.K., Xu C., Loening A.M., Gambhir S.S., and Rao J. Self-illuminating quantum dot conjugates for in vivo imaging. Nat Biotechnol 24 (2006) 339-343
75. Dasari M., Lee D., Erigala V.R., and Murthy N. Chemiluminescent PEG-PCL micelles for imaging hydrogen peroxide. J Biomed Mater Res A 89 (2009) 561-566
76. le Masne de Chermont Q., Chaneac C., Seguin J., Pelle F., Maitrejean S., Jolivet J.P., Gourier D., Bessodes M., and Scherman D. Nanoprobes with near-infrared persistent luminescence for in vivo imaging. Proc Natl Acad Sci U S A 104 (2007) 9266-9271
77. Xu C.T., Svensson N., Axelsson J., Svenmarker P., Somesfalean G., Chen G., Liang H., Liu H., Zhang Z., and Andersson-Engels S. Autofluorescence insensitive imaging using upconverting nanocrystals in scattering media. Appl Phys Lett 93 (2008) 171103-1-171103-3
78. Salthouse C., Hilderbrand S.A., Weissleder R., and Mahmood U. Design and demonstration of a small-animal upconversion imager. Opt Express 16 (2008) 21731-21737
79. Vinegoni C., Razansky D., Hilderbrand S.A., Shao F., Ntziachristos V., and Weissleder R. Transillumination fluorescence imaging in mice using biocompatible upconverting nanoparticles. Opt Lett 34 (2009) 2566-2568
80. Chatterjee D.K., Rufaihah A.J., and Zhang Y. Upconversion fluorescence imaging of cells and small animals using lanthanide doped nanocrystals. Biomaterials 29 (2008) 937-943
81. Hilderbrand S.A., Shao F., Salthouse C., Mahmood U., and Weissleder R. Upconverting luminescent nanomaterials: application to in vivo bioimaging. Chem Commun (2009) 4188-4190. An excellent demonstration for the potential of upconversion imaging agents to image biological structures in vivo.
82. 3+ doped fluoride nanophosphors. Nano Lett 8 (2008) 3834-3838
83. Lim S.F., Riehn R., Ryu W.S., Khanarian N., Tung C.K., Tank D., and Austin R.H. In vivo and scanning electron microscopy imaging of up-converting nanophosphors in Caenorhabditis elegans. Nano Lett 6 (2006) 169-174